☆ 4.4 Editorial Material

Endobronchial Gangliocytic Paraganglioma: Not All Keratin-Positive Endobronchial Neuroendocrine Neoplasms are Pulmonary Carcinoids

ENDOCRINE PATHOLOGY (2014)

Journal

ENDOCRINE PATHOLOGY

Volume 25, Issue 3, Pages 356-358

Publisher

HUMANA PRESS INC

DOI: 10.1007/s12022-013-9258-7

Keywords

-

Categories

Endocrinology & Metabolism Pathology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Pathology

Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours

Sambit Kumar Mohanty, Ankit Tiwari, Nitin Bhardwaj, Fai Chuang, Evelyn Kim, Hector Lugo, Xiaopu Yuan, Sameer Al Diffalha, Mariza Peralta-Venturina, Bonnie Balzer, Deepti Dhall

Summary: Determining the site of origin of a metastatic neuroendocrine tumour (NET) can be challenging and has important prognostic and therapeutic implications. A panel of immunohistochemical (IHC) markers is often employed for this purpose, with SATB2 potentially playing a role in differentiating pancreatic and rectal NETs. Including SATB2 in the panel could improve specificity for pancreaticoduodenal NETs, and complement other markers in determining the site of origin in a metastatic setting.

JOURNAL OF CLINICAL PATHOLOGY (2021)

Add to Collection

Article Oncology

Outcomes and Prognostic Factors of Patients with Metastatic Colorectal Cancer Who Underwent Pulmonary Metastasectomy with Curative Intent: A Brazilian Experience

Gustavo C. L. Gossling, Marcio F. Chedid, Fernando S. Pereira, Rafaela K. da Silva, Leonardo B. Andrade, Nicolas Peruzzo, Mauricio G. Saueressig, Gilberto Schwartsmann, Aparna R. Parikh

Summary: This study aimed to identify clinicopathological and molecular features associated with progression-free survival (PFS) and overall survival (OS) after pulmonary metastasectomy for metastatic colorectal cancer. The findings suggest that disease-free interval, synchronous presentation, and number and size of lesions are significant prognostic factors for OS, while presenting with more than one lesion is predictive for PFS but not for OS.

ONCOLOGIST (2021)

Add to Collection

Article Oncology

The Fibrosis-Targeted Collagen/Integrins Gene Profile Predicts Risk of Metastasis in Pulmonary Neuroendocrine Neoplasms

Tabatha Gutierrez Prieto, Juliana Machado-Rugolo, Camila Machado Baldavira, Ana Paula Pereira Velosa, Walcy Rosolia Teodoro, Alexandre Muxfeldt Ab Sabe, Vera Luiza Capelozzi

Summary: Our study investigated the differential expression of collagen/integrin genes in pulmonary neuroendocrine neoplasms (PNENs) and their association with metastasis. We found that up regulation of fibrogenic genes is a critical molecular event leading to lymph node and distant metastasis in PNENs, which could serve as predictors of patient outcomes.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Endobronchial Ultrasonography with a Guide Sheath Transbronchial Biopsy for Diagnosing Peripheral Pulmonary Lesions within or near Fibrotic Lesions in Patients with Interstitial Lung Disease

Takayasu Ito, Shotaro Okachi, Tomoki Kimura, Kensuke Kataoka, Yasuhiko Suzuki, Fumie Kinoshita, Keiko Wakahara, Naozumi Hashimoto, Yasuhiro Kondoh

Summary: The study assessed the efficacy and complications of bronchoscopy with R-EBUS as the initial diagnostic procedure for diagnosing PPLs in ILD patients, based on the proximity of PPLs to fibrotic lesions. The diagnostic yield for PPLs near fibrotic lesions was significantly lower than for PPLs distant from fibrotic lesions, with the positional relation to fibrotic lesions and probe position being important factors affecting successful diagnosis via EBUS-GS TBB in these patients.

CANCERS (2021)

Add to Collection

Article Pathology

Phox2B is a sensitive and reliable marker of paraganglioma-Phox2B immunohistochemistry in diagnosis of neuroendocrine neoplasms

Monika Manethova, Lucie Gerykova, Hana Faistova, Jan Drugda, Maria Hacova, Helena Hornychova, Ales Ryska, Filip Gabalec, Jiri Soukup

Summary: Phox2B is a transcription factor responsible for the chromaffin cell phenotype. This study assessed the expression of Phox2b in different neuroendocrine neoplasms and found that it is highly expressed in paragangliomas, serving as an additional marker in the differential diagnosis of neuroendocrine tumors.

VIRCHOWS ARCHIV (2023)

Add to Collection

Article Oncology

The Management and Outcomes of Patients with Extra-Pulmonary Neuroendocrine Neoplasms and Brain Metastases

Zainul-Abedin Kapacee, Jennifer Allison, Mohammed Dawod, Xin Wang, Melissa Frizziero, Bipasha Chakrabarty, Prakash Manoharan, Catherine McBain, Was Mansoor, Angela Lamarca, Richard Hubner, Juan W. Valle, Mairead G. McNamara

Summary: This study provides detailed information on the clinicopathological features, management, and outcomes of patients with EP-NENs who developed BMs. The findings show that BMs in EP-NENs patients are rare, especially in those with G3 disease. The treatment of BMs varied, and the survival outcomes were poor.

CURRENT ONCOLOGY (2022)

Add to Collection

Article Immunology

The panel of syntaxin 1 and insulinoma-associated protein 1 outperforms classic neuroendocrine markers in pulmonary neuroendocrine neoplasms

Tamas Zombori, Sandor Turkevi-Nagy, Anita Sejben, Greta Juhasz-Nagy, Gabor Cserni, Jozsef Furak, Laszlo Tiszlavicz, Laszlo Krenacs, Bence Kovari

Summary: Syntaxin-1 (STX1) is a highly sensitive and specific neuroendocrine marker for pulmonary neuroendocrine neoplasms, with a sensitivity of 96.6% surpassing that of classic markers. A panel of STX1 and INSM1 is proposed for routine immunohistochemical workup of pulmonary NENs, showing excellent sensitivity and specificity.

APMIS (2021)

Add to Collection

Article Genetics & Heredity

Proposing Specific Neuronal Epithelial-to-Mesenchymal Transition Genes as an Ancillary Tool for Differential Diagnosis among Pulmonary Neuroendocrine Neoplasms

Tabatha Gutierrez Prieto, Camila Machado Baldavira, Juliana Machado-Rugolo, Eloisa Helena Ribeiro Olivieri, Eduardo Caetano Abilio da Silva, Alexandre Muxfeldt Ab Saber, Teresa Yae Takagaki, Vera Luiza Capelozzi

Summary: This study investigated the expression of EMT genes and their association with PNENs histotypes. The results showed that these EMT genes are involved in cellular processes such as proliferation, extracellular matrix degradation, apoptosis regulation, oncogenesis, and tumor invasion. Four of these EMT genes are also involved in neurological diseases, brain metastasis, and interact with chemotherapy. These findings are important for improving histologic diagnosis and chemotherapeutic strategies in PNENs.

GENES (2022)

Add to Collection

Article Endocrinology & Metabolism

Number of Positive Lymph Nodes Is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms

Bingqiang Gao, Dongkai Zhou, Xiaohui Qian, Yuancong Jiang, Zhenghao Liu, Wang Zhang, Weilin Wang

Summary: The study reviewed clinicopathological and prognostic data of 2,295 patients diagnosed with PanNENs between 1988 and 2015 from the SEER database. PLN and LNR staging were identified as independent prognostic factors, with PLN staging showing better predictive discriminatory capacity.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Article Oncology

Response to selpercatinib in a patient with RET fusion-positive pulmonary large-cell neuroendocrine carcinoma: A case report

Aakriti Arora, Jacob Zaemes, Metin Ozdemirli, Chul Kim

Summary: Large-cell neuroendocrine carcinoma (LCNEC) is a rare subtype of non-small-cell lung cancer associated with a poor prognosis. Comprehensive molecular testing in LCNEC is important for selection of optimal treatment. This case report demonstrates the efficacy of a selective RET inhibitor selpercatinib in a patient with stage IV LCNEC harboring a KIF5B-RET fusion.

FRONTIERS IN ONCOLOGY (2023)

Add to Collection

Article Medicine, General & Internal

A Pilot Study of Transbronchial Biopsy Using Endobronchial Ultrasonography with a Guide Sheath in the Diagnosis of Peripheral Pulmonary Lesions in Patients with Interstitial Lung Disease

Takayasu Ito, Tomoki Kimura, Kensuke Kataoka, Shotaro Okachi, Keiko Wakahara, Naozumi Hashimoto, Yasuhiro Kondoh

Summary: This study demonstrated that using EBUS-GS for TBB is an effective and safe method for diagnosing PPLs in patients with ILD. Compared to conventional TBB, EBUS-GS TBB showed a higher diagnostic yield in small lesions, lesions in the lower lobes, lesions with a positive bronchus sign, and lesions visible on chest radiography.

DIAGNOSTICS (2021)

Add to Collection

Article Oncology

Pulmonary Neuroendocrine Neoplasms Overexpressing Epithelial-Mesenchymal Transition Mechanical Barriers Genes Lack Immune-Suppressive Response and Present an Increased Risk of Metastasis

Tabatha Gutierrez Prieto, Camila Machado Baldavira, Juliana Machado-Rugolo, Cecilia Farhat, Eloisa Helena Ribeiro Olivieri, Vanessa Karen de Sa, Eduardo Caetano Abilio da Silva, Marcelo Luiz Balancin, Alexandre Muxfeldt Ab Saber, Teresa Yae Takagaki, Vladmir Claudio Cordeiro de Lima, Vera Luiza Capelozzi

Summary: This study identified that the upregulation of EMT transcription factors is significantly associated with metastasis in PNENs, suggesting that these factors play a critical role in increasing the risk of metastasis in PNENs.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Three dimensional computed tomography texture analysis of pulmonary lesions: Does radiomics allow differentiation between carcinoma, neuroendocrine tumor and organizing pneumonia?

Gabriel Adelsmayr, Michael Janisch, Heimo Mueller, Andreas Holzinger, Emina Talakic, Elmar Janek, Simon Streit, Michael Fuchsjaeger, Helmut Schoellnast

Summary: This study aimed to investigate whether CT texture analysis can differentiate between different types of lung cancers and tumors. The study included 133 patients who underwent CT-guided biopsy of the lung. The results showed significant differences in texture features between different entities, and the use of a HU threshold affected the results of the analysis. Rating: 7/10

EUROPEAN JOURNAL OF RADIOLOGY (2023)

Add to Collection

Review Oncology

Diagnostic yield of radial probe endobronchial ultrasonography-guided transbronchial biopsy without fluoroscopy in peripheral pulmonary lesions: A systematic review and meta-analysis

Jonghoo Lee, Jae-Uk Song

Summary: This study aimed to determine the diagnostic yield of radial probe endobronchial ultrasound (R-EBUS)-guided transbronchial biopsy (TBB) without fluoroscopy for peripheral pulmonary lesions (PPLs). A systematic literature review and meta-analysis were performed, and factors affecting the performance of R-EBUS-guided TBB without fluoroscopy were identified. The overall diagnostic yield was 0.70 (95% CI, 0.67-0.74), and factors such as air bronchus sign, larger size PPLs, probe location within lesions, and heterogeneous echogenicity were associated with higher diagnostic yield. The pneumothorax rate was low (0.01, 95% CI, 0.01-0.01). However, caution should be exercised when interpreting the results due to substantial between-study heterogeneity.

THORACIC CANCER (2023)

Add to Collection

Article Medicine, General & Internal

Quantitative Airway Assessment of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) on CT as a Novel Biomarker

Cormac O'Brien, John A. A. Duignan, Margaret Gleeson, Orla O'Carroll, Alessandro N. N. Franciosi, Dermot O'Toole, Aurelie Fabre, Rachel K. K. Crowley, Cormac McCarthy, Jonathan D. D. Dodd, David J. J. Murphy

Summary: This study conducted a quantitative CT airway analysis in patients with DIPNECH and found increased airway wall thickness and airway:artery ratio compared to controls. These quantitative CT measurements may serve as potential imaging biomarkers to evaluate treatment response.

DIAGNOSTICS (2022)

Add to Collection

Article Endocrinology & Metabolism

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

Guido Rindi, Ozgur Mete, Silvia Uccella, Olca Basturk, Stefano La Rosa, Lodewijk A. A. Brosens, Shereen Ezzat, Wouter W. de Herder, David S. Klimstra, Mauro Papotti, Sylvia L. Asa

Summary: In this review, the changes and features of neuroendocrine neoplasms (NENs) in the 2022 WHO Classification of Endocrine and Neuroendocrine Tumors are detailed. The consolidation of nomenclature distinguishing different neoplasms and the importance of Ki67 as a tool for classification and grading are emphasized. The clinical relevance of proper classification and the tools available to pathologists for accurate classification are explained. The article also discusses the differential diagnoses and theranostic biomarkers for NENs, as well as the role of pathologists in identifying precursor lesions and applying molecular immunohistochemistry.

ENDOCRINE PATHOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

Overview of the 2022 WHO Classification of Adrenal Cortical Tumors

Ozgur Mete, Lori A. Erickson, C. Christofer Juhlin, Ronald R. de Krijger, Hironobu Sasano, Marco Volante, Mauro G. Papotti

Summary: The new WHO classification of adrenal cortical proliferations reflects translational advances in endocrine pathology, oncology, and molecular biology. It highlights the understanding of adrenal cortex pathologies through histological features, ancillary studies, and genetic findings, leading to advances in knowledge of these conditions. The classification redefines the spectrum of adrenal cortical nodular disease, emphasizing the importance of accurate assessment of tumor proliferation rate and diagnostic biomarkers in the workup of adrenal cortical neoplasms.

ENDOCRINE PATHOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas

Ozgur Mete, Sylvia L. Asa, Anthony J. Gill, Noriko Kimura, Ronald R. de Krijger, Arthur Tischler

Summary: This review provides a comprehensive overview of the classification, pathogenesis, biomarkers, and diagnostic criteria of tumors of the adrenal medulla and extra-adrenal paraganglia. It also introduces new genetic predisposition syndromes and changes in tumor nomenclature.

ENDOCRINE PATHOLOGY (2022)

Add to Collection

Editorial Material Endocrinology & Metabolism

The Next Steps for Endocrine Pathology

Sylvia L. Asa, Lori A. Erickson, Ozgur Mete

ENDOCRINE PATHOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers

Lucy X. Ma, Osvaldo Espin-Garcia, Philippe L. Bedard, Tracy Stockley, Rebecca Prince, Ozgur Mete, Monika K. Krzyzanowska

Summary: This study analyzes the actionability and clinical use of NGS results in advanced thyroid cancer. Most patients had at least one potentially actionable mutation and 57% of patients had at least one Level 1 or 2 alteration, predominantly driven by BRAF V600E and RET alterations. This study rationalizes the need for routine multigene NGS testing or reflex BRAF and RET testing in the management of patients with advanced thyroid cancer.

THYROID (2022)

Add to Collection

Article Genetics & Heredity

VHL mosaicism: the added value of multi-tissue analysis

Leslie E. Oldfield, Jessica Grzybowski, Sylvie Grenier, Elizabeth Chao, Gregory S. Downs, Kirsten M. Farncombe, Tracy L. Stockley, Ozgur Mete, Raymond H. Kim

Summary: This report highlights the importance of tissue testing in VHL variant negative cases, using a rare case of VHL mosaicism as an example.

NPJ GENOMIC MEDICINE (2022)

Add to Collection

Editorial Material Endocrinology & Metabolism

Medullary Thyroid Carcinoma in the IARC/WHO Neuroendocrine Schema

Sylvia L. Asa, Ozgur Mete

ENDOCRINE PATHOLOGY (2022)

Add to Collection

Editorial Material Endocrinology & Metabolism

Oncological Outcome Prediction in Differentiated Thyroid Carcinoma: Assumption or Improved Accuracy?

Ozgur Mete, Sylvia L. Asa

THYROID (2022)

Add to Collection

Article Endocrinology & Metabolism

FLCN-Driven Functional Adrenal Cortical Carcinoma with High Mitotic Tumor Grade: Extending the Endocrine Manifestations of Birt-Hogg-Dube Syndrome

Renee Hofstedter, Maria Carolina Sanabria-Salas, Maria Di Jiang, Shereen Ezzat, Ozgur Mete, Raymond H. Kim

Summary: Adrenal cortical carcinoma is a rare and aggressive malignancy that originates from steroidogenic cells of the adrenal gland. It is often sporadic but can be associated with inherited tumor syndromes. There have been very few reports of adrenal cortical neoplasia in patients with BHD syndrome. We present a case of adrenal cortical carcinoma in a 50-year-old female with a germline pathogenic variant in the FLCN gene. Genetic testing revealed the same variant in the tumor, suggesting its contribution to the pathogenesis of adrenal cortical carcinoma. This case expands our understanding of BHD syndrome and highlights the importance of genetic testing for FLCN in patients with adrenal cortical carcinomas.

ENDOCRINE PATHOLOGY (2023)

Add to Collection

Review Oncology

The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading

C. Christofer Juhlin, Ozgur Mete, Zubair W. Baloch

Summary: The World Health Organization has released the fifth edition of the Classification of Endocrine and Neuroendocrine Tumors. This publication includes changes to the nomenclature of thyroid diseases and introduces novel concepts important for patient management. The classification now groups non-neoplastic and benign neoplastic lesions under 'thyroid follicular nodular disease', reflecting their clonal and non-clonal proliferations in multinodular goiter. Thyroid neoplasms originating from follicular cells are categorized into benign, low-risk, and malignant neoplasms, emphasizing the subtyping of papillary thyroid carcinoma based on histomorphologic features and redefining the cribriform-morular variant as cribriform-morular thyroid carcinoma. The review highlights the key changes in the fifth edition and their impact on patient management and future directions in this field.

ENDOCRINE-RELATED CANCER (2023)

Add to Collection

Letter Endocrinology & Metabolism

Progress in Adrenal Cortical Neoplasms: From Predictive Histomorphology to FLCN-Driven Germline Pathogenesis and the Prognostic Performance of Multiparameter Scoring Systems in Pediatric Adrenal Cortical Neoplasms

Ozgur Mete, C. Christofer Juhlin

ENDOCRINE PATHOLOGY (2023)

Add to Collection

Article Endocrinology & Metabolism

Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1

Sylvia L. Asa, Ozgur Mete, Nicole D. Riddle, Arie Perry

Summary: This study identified a rare type of pituitary neuroendocrine tumors (PitNETs) that express both PIT1 and SF1 transcription factors. These tumors exhibit variable clinical and morphological features, commonly presenting as large tumors with growth hormone excess and occasionally coexisting with other types of PitNETs.

ENDOCRINE PATHOLOGY (2023)

Add to Collection

Article Endocrinology & Metabolism

Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma

Chan Kwon Jung, Shipra Agarwal, Jen-Fan Hang, Dong-Jun Lim, Andrey Bychkov, Ozgur Mete

Summary: This review provides an overview of the molecular genetics, pathology, and treatment of medullary thyroid carcinoma (MTC). It emphasizes the importance of distinguishing MTC from other neuroendocrine tumors and recommends routine testing for RET gene mutations in all MTC patients, as well as somatic RET alterations in advanced/progressive or metastatic diseases. Additionally, the option of Lu-177-DOTATATE peptide radionuclide receptor therapy may benefit patients with SSTR-avid metastatic disease. Lastly, the authors call for a change in the nomenclature of MTC to C-cell neuroendocrine neoplasm to align with the IARC/WHO taxonomy.

ENDOCRINE PATHOLOGY (2023)

Add to Collection

Book Review Endocrinology & Metabolism

3rd Edition of Diagnostic Pathology: Endocrine by Vania Nose

Ozgur Mete

ENDOCRINE PATHOLOGY (2023)

Add to Collection

Book Review Endocrinology & Metabolism

The Atlas of Non-neoplastic Disorders of the Endocrine System

Ozgur Mete

ENDOCRINE PATHOLOGY (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.